bioMérieux has published a groundbreaking health economic analysis demonstrating that early deployment of fast identification and antimicrobial susceptibility testing (ID/AST) can significantly reduce the progression of bloodstream infections to sepsis, thereby improving patient outcomes and generating substantial cost savings across multiple healthcare systems, including Canada, France, Germany, Italy, Japan, the UK, and the US. Conducted by the Office of Health Economics, this analysis provides the first robust evidence supporting the clinical and economic advantages of integrating rapid diagnostics early in the care pathway for high-risk patients.

The analysis highlights that sepsis is a leading preventable cause of death, responsible for approximately 21 million deaths globally each year. Traditional diagnostic methods often take two to three days, during which time critical treatment decisions must be made with incomplete information, leading to inappropriate initial therapies for nearly 20% of patients. The model-based evaluation indicates that implementing fast ID/AST can prevent thousands from deteriorating into sepsis or septic shock annually, reducing sepsis cases by over 20% and lowering mortality rates. Moreover, the early use of these diagnostics is projected to save healthcare systems between $1,000 per patient in Canada, accumulating to an estimated $42 million annually in savings from avoided acute care costs and long-term complications.

The findings advocate for a paradigm shift in how diagnostics are valued within healthcare systems. Currently, diagnostics represent a small fraction of spending, yet their potential to generate significant value is not adequately recognized. The analysis calls for urgent policy reforms to update reimbursement structures, enhance diagnostic capacities, and align incentives, ensuring that fast testing is integrated early in clinical pathways. This evidence underscores the need for further real-world studies to confirm these findings and emphasizes the critical role of rapid diagnostics in improving patient care and system efficiency.

Source: globenewswire.com